オキシコドン

オキシコドン 化学構造式
76-42-6
CAS番号.
76-42-6
化学名:
オキシコドン
别名:
ジヒドロヒドロキシコデイノン;3-メトキシ-14-ヒドロキシ-17-メチル-4,5α-エポキシモルフィナン-6-オン;6-オキソ-14-ヒドロキシ-7,8-ジヒドロコデイン;(-)-4,5α-エポキシ-14-ヒドロキシ-3-メトキシ-17-メチルモルフィナン-6-オン;14-ヒドロキシジヒドロコデイノン;ジヒドロン;(-)-14-ヒドロキシジヒドロコデイノン;オキシコデイノン;(5R)-4,5-エポキシ-14-ヒドロキシ-3-メトキシ-17-メチルモルフィナン-6-オン;オキシコドン;4,5α-エポキシ-14-ヒドロキシ-3-メトキシ-17-メチルモルフィナン-6-オン;14-ヒドロキシ-3-メトキシ-17-メチル-4,5α-エポキシモルフィナン-6-オン;(1S,5R,13R,17S)-17-ヒドロキシ-10-メトキシ-4-メチル-12-オキサ-4-アザペンタシクロ[9.6.1.01,13.05,17.07,18]オクタデカ-7,9,11(18)-トリエン-14-オン;(-)-オキシコドン
英語名:
OXYCODONE
英語别名:
percocet;Oxycodon;endone;Percodan;Dihydrohydroxycodeinone;14-Hydroxydihydrocodeinone;Oxicon;oxanest;Oxicone;OXYCODONE
CBNumber:
CB5166312
化学式:
C18H21NO4
分子量:
315.36
MOL File:
76-42-6.mol

オキシコドン 物理性質

融点 :
218-220°
沸点 :
454.92°C (rough estimate)
比重(密度) :
1.2164 (rough estimate)
屈折率 :
1.5740 (estimate)
闪点 :
9℃
貯蔵温度 :
2-8°C
溶解性:
DMF: 20 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 10 mg/ml
外見 :
A neat solid
酸解離定数(Pka):
8.53(at 25℃)
色:
EtOH からの長いロッド
EPAの化学物質情報:
Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5.alpha.)- (76-42-6)
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
主な危険性  F,T
Rフレーズ  11-23/24/25-39/23/24/25
Sフレーズ  7-16-36/37-45
RIDADR  1544
WGK Germany  1
国連危険物分類  6.1(a)
容器等級  II
HSコード  2939110000
有毒物質データの 76-42-6(Hazardous Substances Data)
毒性 LD50 intraperitoneal in mouse: 320mg/kg
絵表示(GHS) GHS hazard pictograms
注意喚起語 警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H302 飲み込むと有害 急性毒性、経口 4 警告 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H336 眠気やめまいのおそれ 特定標的臓器毒性、単回暴露; 麻酔作用 3 警告 P261, P271, P304+P340, P312,P403+P233, P405, P501
H362 授乳中の子に害を及ぼすおそれ 生殖毒性、授乳に対するまたは 授乳を介したの影響 追加区分 P201, P260, P263, P264, P270,P308+P313
注意書き
P202 全ての安全注意を読み理解するまで取り扱わないこ と。
P260 粉じん/煙/ガス/ミスト/蒸気/スプレーを吸入しないこ と。
P263 妊娠中/授乳期中は接触を避けること。
P264 取扱い後は皮膚をよく洗うこと。
P264 取扱い後は手や顔をよく洗うこと。
P301+P312 飲み込んだ場合:気分が悪い時は医師に連絡する こと。
P308+P313 暴露または暴露の懸念がある場合:医師の診断/手当てを 受けること。

オキシコドン 化学特性,用途語,生産方法

効能

麻薬性鎮痛薬, オピオイド受容体作動薬

説明

Oxycodone (Item No. 15465) is an analytical reference material categorized as an opioid. Oxycodone is regulated as a Schedule II compound in the United States. This product is intended for research and forensic applications.

使用

Analgesic (narcotic).

定義

oxycodone: An opioid, C18H21N2,similar in structure to codeine butwith a –OH group in codeine replacedby a carbonyl group. It is ananalgesic often used for the treatmentof chronic pain. It is also usedillegally and is a controlled substancein most countries.

生物学の機能

Oxycodone is nearly 10 times as strong as codeine, with absorption equal to that of orally administered morphine. Neither hydromorphone nor oxycodone is approved for use in children, and hydromorphone is contraindicated in obstetrical analgesia and in asthmatics.

一般的な説明

Oxycodone is synthesized from the natural opium alkaloidthebaine. Oxycodone is the 14 beta-hydroxyl version of hydrocodone.This additional functional group gives oxycodonegreater potency (1.5 times orally) than hydrocodone presumablyby increasing receptor affinity. The oral bioavailabilityof oxycodone is 65% to 87%. The metabolism of oxycodonefollows the similar pattern of opioid metabolism withN-demethylation, O-demethylation, and their glucuronides allidentified. Per the manufacturer, the analgesic effect of oxycodonecorrelates well with oxycodone plasma concentrations,not the minimal amount of oxymorphone formed, thusoxycodone is not assumed to be a prodrug. There are no largescalestudies of oxycodone used for analgesia in CYP2D6poor metabolizers that can confirm this.
Oxycodone is marketed in combination with acetaminophen(Percocet), aspirin (Percodan), and ibuprofen(Combunox). It has been available for over 50 years as animmediate-release tablet, and in 1995 an extended-releasetablet was approved by the FDA (OxyContin). OxyContin ismanufactured in eight strengths from 10 to 160 mg, and thehigh-dose preparations quickly became attractive to drugabusers. The extended-release tablets are crushed and theninjected or snorted to give an immediate high. The DrugAbuse Warning Network (DAWN) is a public health surveillancesystem that monitors drug-related emergency roomvisits and drug-related deaths. In 1995, they estimated that598,542 emergency room visits involved the nonmedical useof a pharmaceutical (e.g., antidepressant, anxiolytic, stimulant).Of these ER visits, 160,363 visits were attributed toopiates with an estimated 42,810 involving oxycodone or anoxycodone combination. Methadone and hydrocodone/combinationswere estimated to be similar to oxycodone.

薬理学

Oxycodone is a potent semisynthetic opioid that has been in use for many years. In addition to actions at the MOP receptor, it may also have analgesic effects mediated via the KOP receptor, resulting in incomplete crosstolerance with morphine. It has a good oral bioavailability, and its plasma concentrations are more predictable than those of morphine after oral administration. It is available in both long- and short-acting oral preparations and, more recently, in a parenteral formulation. Oral oxycodone is roughly 1.5 times more potent than oral morphine.

安全性プロファイル

Poison by intraperitoneal route. Moderately toxic by subcutaneous route. When heated to decomposition it emits toxic fumes of NOx.

オキシコドン 上流と下流の製品情報

原材料

準備製品

76-42-6(オキシコドン)キーワード:


  • 76-42-6
  • OXYCODONE
  • 4,5-alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-morphinan-6-on
  • 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-morphinan-6-on
  • 4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
  • eubine(france)
  • Eucodalum
  • Morphinan-6-one, 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-
  • Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)-
  • NSC-19043
  • oxanest
  • Oxicon
  • Oxicone
  • Oxycodeinone
  • pancodoneretard(unitedkingdom)
  • Percobarb
  • supendol(canada)
  • 4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
  • 4aH-8,9c-Iminoethanophenanthro(4,5-bcd)furan-5(6H)-one, 7,7a,8,9-tetrahydro-7a-hydroxy-3-methoxy-12-methyl-
  • 5-epoxy-14-hydroxy-3-methoxy-17-methyl-(5alpha)-morhinan-6-on
  • 7,8-dihydro-14-hydroxy-codeinon
  • OXYCODONE/4,5-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE
  • 4Ah-8,9C-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one, 7,7A,8,9-tetrahydro-7A-hydroxy-3-methoxy-12-methyl-
  • Oxycodone, 1.0 mg/mL
  • Oxycodone CII (200 mg)
  • Oxycodone solution
  • Codeinone, 7,8-dihydro-14-hydroxy-
  • Codeinone, dihydro-14-hydroxy-
  • Codeinone, dihydrohydroxy-
  • dihydro-14-hydroxy-codeinon
  • Dihydro-14-hydroxycodeinone
  • ジヒドロヒドロキシコデイノン
  • 3-メトキシ-14-ヒドロキシ-17-メチル-4,5α-エポキシモルフィナン-6-オン
  • 6-オキソ-14-ヒドロキシ-7,8-ジヒドロコデイン
  • (-)-4,5α-エポキシ-14-ヒドロキシ-3-メトキシ-17-メチルモルフィナン-6-オン
  • 14-ヒドロキシジヒドロコデイノン
  • ジヒドロン
  • (-)-14-ヒドロキシジヒドロコデイノン
  • オキシコデイノン
  • (5R)-4,5-エポキシ-14-ヒドロキシ-3-メトキシ-17-メチルモルフィナン-6-オン
  • オキシコドン
  • 4,5α-エポキシ-14-ヒドロキシ-3-メトキシ-17-メチルモルフィナン-6-オン
  • 14-ヒドロキシ-3-メトキシ-17-メチル-4,5α-エポキシモルフィナン-6-オン
  • (1S,5R,13R,17S)-17-ヒドロキシ-10-メトキシ-4-メチル-12-オキサ-4-アザペンタシクロ[9.6.1.01,13.05,17.07,18]オクタデカ-7,9,11(18)-トリエン-14-オン
  • (-)-オキシコドン
  • 麻薬性鎮痛薬
  • 鎮咳薬
Copyright 2017 © ChemicalBook. All rights reserved